Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

AZN
AstraZeneca PLC
stock NASDAQ ADR

At Close
Jul 8, 2025 3:59:57 PM EDT
70.03USD+0.574%(+0.40)4,079,532
69.50Bid   70.04Ask   0.54Spread
Pre-market
Jul 8, 2025 9:20:30 AM EDT
69.43USD-0.287%(-0.20)12,817
After-hours
Jul 8, 2025 4:32:30 PM EDT
70.03USD0.000%(0.00)47,728
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
02:17PM EST  Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?   Benzinga
12:44PM EST  Pfizer, AstraZeneca or J&J COVID-19 Shots Boost Sinovac Regime, Brazilian Study Shows   Benzinga
09:26AM EST  Ionis' Eplontersen Receives FDA Orphan Drug Status For Misfolded Protein Disorder   Benzinga
07:58AM EST  From Oxford: Third Booster Of Either AstraZeneca, Pfizer, Janssen Or Sinovac COVID Shot Induce Higher Antibodies In Those Who Previously Got Two Sinovac Doses   Benzinga
07:19AM EST  Ionis' Eplontersen Receives Orphan Drug Designation from the FDA   Benzinga
07:18AM EST  AstraZeneca' Eplontersen Granted Orphan Drug Designation In US For Transthyretin Amyloidosis   RTTNews
07:10AM EST  Eplontersen granted Orphan Drug Designation in the US for transthyretin amyloidosis   Business Wire
Jan 21, 2022
08:41AM EST  Lower COVID-19 Vaccine Sales Estimated Amid Less Severe Omicron Variant: Bloomberg   Benzinga
Jan 19, 2022
12:50PM EST  AstraZeneca Rolls Out "Unprecedented' Three Year Survival Data For Imfinzi/Treme Combo In Liver Cancer   Benzinga
04:54AM EST  AstraZeneca Announced MFINZI (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years   Benzinga
04:53AM EST  AstraZeneca Announced IMFINZI Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer   Benzinga
Jan 18, 2022
05:50PM EST  IMFINZI(r) (durvalumab) Plus Tremelimumab Demonstrated Unprecedented Survival in 1st-line Unresectable Liver Cancer With 31% of Patients Alive at Three Years   Business Wire
05:20PM EST  IMFINZI(r) (durvalumab) Plus Chemotherapy Reduced Risk of Death by 20% in 1st-Line Advanced Biliary Tract Cancer   Business Wire
Jan 17, 2022
07:41PM EST  CORRECTING and REPLACING ENHERTU(r) granted Priority Review in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen   Business Wire
07:00AM EST  Enhertu Granted Priority Review in the US for Patients With HER2-Positive Metastatic Breast Cancer Treated With a Prior Anti-HER2-Based Regimen   Business Wire
02:13AM EST  AstraZeneca: Enhertu Granted Priority Review In The US For Patients With HER2-positive Metastatic Breast Cancer   RTTNews
Jan 16, 2022
04:38PM EST  The Week Ahead In Biotech (Jan 16-22): Focus On Data Presentations And IPOs In Holiday-Shortened Week   Benzinga
Jan 13, 2022
02:30PM EST  Supreme Court Blocks President Biden's Workplace Vaccine-Or-Test Mandate For Larger Employers; Grants Administration Request To Enforce Vaccine Mandate For Healthcare Workers Nationwide   Benzinga
11:47AM EST  The Daily Biotech Pulse: Adagio's Antibody Effective Against Omicron, Sarepta Terminates Gene Therapy Deal, AstraZeneca Inks Oncology Pact   Benzinga
11:45AM EST  Amgen And AstraZeneca Announce Availability Of TEZSPIRE For Shipment To Wholesalers In US   Benzinga
11:45AM EST  AstraZeneca Sells Additional Half-Million Doses Of Its COVID-19 Antibody To US   Benzinga
11:45AM EST  AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use   Benzinga
11:45AM EST  Scorpion Therapeutics Enters Agreement With AstraZeneca To Discover, Develop And Commercialize Novel Cancer Treatments Against 'Undruggable' Targets; Scorpion Will Receive An Upfront Cash Payment Of $75M And Is Eligible To Receive Up To An Additional $1.5   Benzinga
11:45AM EST  Astrazeneca And Amgen Today Announced TEZSPIRE Is Now Available For Shipment To Wholesalers In The U.S.   Benzinga
11:43AM EST  Scorpion Therapeutics, AstraZeneca Ink Precision Medicines Pact For Hard-To-Target Cancer Proteins   Benzinga
11:43AM EST  AstraZeneca Announced New data from ongoing Trial of Vaxzevria Showed Increased Antibody Response Against Beta, Delta, Alpha, Gamma, Omicron Variants Following Third Dose Booster   Benzinga
11:43AM EST  AstraZeneca Announced it Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment with Imfinzi and Lynparza Data to be Presented at ASCO Genitourinary Cancers Symposium   Benzinga
11:43AM EST  AstraZeneca and Scorpion Therapeutics Enter Agreement to Discover, Develop and Commercialize Novel Cancer Treatments Against Undruggable Targets; Scorpion to Receive an Upfront Cash Payment of $75M, Plus Potential Milestone Payments, Royalties   Benzinga
07:12AM EST  AstraZeneca To Present New Data In Liver, Biliary Tract And Prostate Cancers At ASCO GI And GU   RTTNews
07:05AM EST  AstraZeneca Aims to Redefine Liver, Biliary Tract and Prostate Cancer Treatment With Practice-Changing IMFINZI(r) (durvalumab) and LYNPARZA(r) (olaparib) Data at ASCO GI and GU   Business Wire
07:00AM EST  TEZSPIRE Now Available in the United States for the Treatment of Severe Asthma   Business Wire
Jan 11, 2022
10:25AM EST  EU Drug Regulator Says Should Be Careful In Not Overloading Immune System With Repeated COVID-19 Immunization   Benzinga
08:36AM EST  The Daily Biotech Pulse: Illumina Announces Multiple Partnerships, Immunome Slides On Regulatory Setback For COVID Antibody Drug, Preannouncements Pour In   Benzinga
Jan 10, 2022
04:33PM EST  Fusion Pharmaceuticals Announces Nomination Of First Targeted Alpha Therapy Candidate In Collaboration With AstraZeneca To Advance Into IND-Enabling Studies For Phase 1 Development   Benzinga
04:30PM EST  Candidate in Collaboration with AstraZeneca to Advance into IND-Enabling Studies for Phase 1 Development   PR Newswire
Jan 7, 2022
01:01PM EST  AstraZeneca Unit Alexion, Neurimmune Signed Exclusive Global Collaboration and License Agreement to Develop and Commercialize NI006   Benzinga
Jan 6, 2022
01:54PM EST  White House Says Vaccine Mandates Related To Schools Are Always Up To School Districts   Benzinga
Jan 5, 2022
04:55AM EST  AstraZeneca Announced Transfer of Global Rights to Eklira, Duaklir Completed; AstraZeneca Received a Payment of $270M from Covis Pharma.   Benzinga
Jan 4, 2022
11:06PM EST  Cannabis Movers & Shakers: Aurora Bolsters Management, Curaleaf Names New Pres, Verano & Avicanna's New Appointments   Benzinga
09:37AM EST  CDC Recommends Pfizer Booster At 5 Months, Additional Primary Dose For Certain Immunocompromised Children   Benzinga
04:27AM EST  Shanghai Junshi Biosciences Scraps Agreement With AstraZeneca On Medicine Toripalimab Injection   Benzinga
04:25AM EST  Australia's Therapeutic Goods Administration Granted Provisional Determination to AstraZeneca for Covid-19 Prophylaxis and Treatment, Tixagevimab and Cilgavimab; Now Includes Prevention and Treatment of Covid-19 in Individuals Aged 12 Years and Older   Benzinga
Jan 3, 2022
07:26AM EST  Ovid Therapeutics Expands Its Anti-Epileptic Franchise With AstraZeneca Licensing Pact   Benzinga
06:36AM EST  Ovid Therapeutics Pays AstraZeneca $5M Cash and 7.5M Shares of Stock for a Library of Early-Stage Small Molecules Targeting the KCC2 Transporter   Benzinga
Jan 2, 2022
03:30PM EST  The Week Ahead In Biotech (Jan 2-Jan. 8): Stray Clinical Readouts In Focus In Slow News Week   Benzinga
Dec 31, 2021
05:23AM EST  India's Serum Institute Applied to India's Drug Regulator and Health Ministry for Full Approval of Covishield Vaccine Under License from AstraZeneca   Benzinga
Dec 30, 2021
11:47AM EST  'F.D.A. Is Said to Be Near Allowing Boosters for 12- to 15-Year-Olds' -New York Times Report   Benzinga
Dec 27, 2021
01:28PM EST  China Comes Out In Support of Continued U.S. Listings With Stronger Oversight   Benzinga
Dec 23, 2021
12:20PM EST  Oxford Lab Study Suggests AstraZeneca's COVID-19 Booster Works Against Omicron   Benzinga
08:09AM EST  AstraZeneca Partner Daiichi Sankyo Reports First Patient Dosed In DESTINY-Lung04 Phase 3 Trial Evaluating ENHERTU   Benzinga
07:05AM EST  AstraZeneca' EVUSHELD Antibody Combination Retains Neutralizing Activity Against Omicron Variant In Studies From Oxford   RTTNews
07:00AM EST  EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in studies from Oxford and Washington Universities   Business Wire
05:56AM EST  U.S. Equity Futures Higher Ahead of Christmas Weekend; Positive News on Effectiveness of Vaccines Against Omicron Variant   Benzinga
05:17AM EST  AstraZeneca Announced Evusheld Long-acting Antibody Combination Retains Neutralising Activity Against Omicron Variant in Studies From Oxford and Washington Universities   Benzinga
Dec 22, 2021
03:26PM EST  'In @WHCOVIDResponse briefing, Zients gives update on supply in what he calls the nation's medicine cabinet for #covid19. In Jan.: 265K courses of Pfizer drug, 3M of Merck drug (if authorized), 500K+ of AZN preventive antibody, 300K of Vir/GSK antibody'   Benzinga
05:38AM EST  U.S. Equity Futures Lower, European Markets Mixed; Governments Across the World Tighten Restrictions Due to Omicron Surge; Tech Companies Cancel Out of CES Vegas Event   Benzinga
Dec 21, 2021
03:36PM EST  'Majority in the Immunization Committee in Israel votes for the provision of a fourth vaccine dose to at-risk groups - vaccine-suppressed, adults over the age of 60 and health care workers.' -Israel Reporter Tweet   Benzinga
10:24AM EST  NYC Mayor's Office Tweets '@NYCMayor just announced a new $100 incentive for New Yorkers if they get their booster shot at City-run sites before December 31.'   Benzinga
04:36AM EST  AstraZeneca Announced Ultomiris Regulatory Submission Accepted under FDA Priority Review in the US for Adults with Generalized Myasthenia Gravis   Benzinga
Dec 20, 2021
11:34AM EST  WHO's Chief Scientist Says 'Very Dangerous' To Jump To Conclusion That All Vaccines, Except mRNA Shots, Are Not Working Against Omicron Variant   Benzinga
05:28AM EST  U.S. Equity Futures, European Markets Fall Sharply Over Rising Omicron Concerns; Two U.S. Senators Test Positive for Covid-19; Moderna Said Booster Effective vs Omicron; Senator Manchin Says he Will Not Support Biden Spending Bill   Benzinga
05:20AM EST  AstraZeneca - Amgen's Tezspire Biologic Scores FDA Approval For Severe Asthma   Benzinga
04:45AM EST  AstraZeneca Announced Saphnelo Recommended for Approval in the EU by CHMP for the Treatment of Patients with Systemic Lupus Erythematosus   Benzinga
04:44AM EST  AstraZeneca Announced Tezspire Approved in the US for Severe Asthma   Benzinga
Dec 19, 2021
07:20PM EST  New Jersey Democratic Senator Cory Booker Says He Has Tested Positive for Covid-19   Benzinga
05:16PM EST  Massachusetts Senator Warren Tests Positive for Covid-19   Benzinga
12:54PM EST  The Week Ahead In Biotech (Dec. 19-25): Amgen And Aquestive Regulatory Decisions Key Events Of Holiday-Shortened Week   Benzinga
Dec 16, 2021
01:57PM EST  World Trade Organization Chief Says Parties Getting Close To Solution In Dispute Over COVID-19 Vaccine Rights   Benzinga
01:27PM EST  AstraZeneca's COVID-19 Antibody Effective Against Omicron Variant   Benzinga
10:02AM EST  AstraZeneca's EVUSHELD Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant : New Preclinical Data   RTTNews
09:58AM EST  EVUSHELD long-acting antibody combination retains neutralizing activity against Omicron variant in independent FDA study   Business Wire
09:11AM EST  AstraZeneca Says Evusheld 'retained neutralising activity against the Omicron SARS-CoV-2 variant'   Benzinga
05:53AM EST  Odyssey Acquisition Announced BenevolentAI Achieves Second Major Collaboration Milestone With Novel Idiopathic Pulmonary Fibrosis Target Selected for AstraZeneca's Portfolio   Benzinga
Dec 15, 2021
11:13AM EST  Sanofi, Glaxo's COVID-19 Vaccine Candidate Works As Booster, But Data Readout Pushed Back   Benzinga
05:01AM EST  Transgene Announced License Option Exercise by AstraZeneca for Oncolytic Virus Generated by Transgene's Invir.IO Platform   Benzinga
01:37AM EST  Transgene : License Option Exercise By AstraZeneca For Oncolytic Virus Generated By Transgene's Invir.IO Platform   RTTNews
Dec 14, 2021
11:27AM EST  World Health Organization Chief Tedros Says People Are Wrong To Consider Omicron Variant As Causing Mild Disease, That Sentiment Could Overwhelm Unprepared Health Systems   Benzinga
10:16AM EST  NFL Mandates Booster Shots Among Team Staff   Benzinga
08:22AM EST  The Daily Biotech Pulse: Mesoblast, Novartis Sever COVID-19 Treatment Partnerships, Sigilon To Reduce Workforce, ASH Presentations Move Stocks   Benzinga
08:12AM EST  Samsung Biologics, AstraZeneca Expand Collaboration To Include COVID-19, Cancer Therapy   Benzinga
04:49AM EST  Samsung Biologics and AstraZeneca Announced Expanded Strategic Manufacturing Partnership to Include COVID-19 and Cancer Therapy   Benzinga
Dec 13, 2021
08:05PM EST  Samsung Biologics, AstraZeneca Expand Strategic Manufacturing Partnership To Include COVID-19 And Cancer Therapy   RTTNews
07:56PM EST  Samsung Biologics and AstraZeneca expand strategic manufacturing partnership to   PR Newswire
11:24AM EST  UK Reports First Omicron Death, PM Johnson Encourages Boosters   Benzinga
05:12AM EST  University of Oxford Study Shows Two-dose Covid-19 Vaccine Regimens Do Not Induce Enough Neutralizing Antibodies vs Omicron Coronavirus Variant   Benzinga
Dec 12, 2021
04:56PM EST  The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More   Benzinga
10:00AM EST  CALQUENCE reduced the risk of disease progression or death by 71% vs. standard of care combinations at three years in the ASCEND Phase III trial   Business Wire
Dec 10, 2021
12:46PM EST  AstraZeneca's Dapagliflozin No Longer Authorized For Type 1 Diabetes In UK   Benzinga
11:43AM EST  UK Health Security Agency Says Booster Increases Protection Against Mild COVID Disease To Around 70%-75% In Real World Study Looking At 581 People With Confirmed Omicron Variant   Benzinga
06:40AM EST  AstraZeneca Shares Lower After UK's Medicines & Healthcare Products Regulatory Agency Says Dapagliflozin No Longer Authorized For Treatment Of Type 1 Diabetes Mellitus   Benzinga
Dec 9, 2021
09:56PM EST  'Gov. Kathy Hochul said she will announce new policies tomorrow as more cases of the Omicron variant are confirmed in New York.' -CBS New York   Benzinga
09:49PM EST  AstraZeneca Highlights Presentation Of ENHERTU Analyses At SABCS 2021   Benzinga
09:47PM EST  AstraZeneca's COVID-19 Therapy Wins FDA Approval As First Antibody To Prevent Infection In Immunocompromised   Benzinga
09:46PM EST  The Daily Biotech Pulse: Reata Plunges On Adcom Snub, AstraZeneca Antibody Cocktail Authorized For COVID-19 Prevention, NeuroSense IPO   Benzinga
09:42PM EST  'Senate votes to repeal key Biden administration vaccine and testing policy' -Earlier Washington Post Report   Benzinga
09:38PM EST  UPDATE: FDA Says Issued Emergency Use Authorization For AstraZeneca's EvuShield For Pre-Exposure Prevention Of COVID-19 In Certain Individuals   Benzinga
09:38PM EST  AstraZeneca Shares Quiet Following Report FDA Authorized New Long-Acting Monoclonal Antibodies For Pre-Exposure Prevention Of COVID-19 In Certain Individuals   Benzinga
10:05AM EST  ENHERTU(r) (fam-trastuzumab deruxtecan-nxki) Additional Analyses Further Reinforce Ground-breaking Efficacy in Patients With HER2-positive Metastatic Breast Cancer   Business Wire
02:13AM EST  AstraZeneca's Evusheld Gets Emergency Use Authorisation In The US For Pre-exposure Prophylaxis (prevention) Of COVID-19   RTTNews
Dec 8, 2021
07:56PM EST  AstraZeneca's EVUSHELD Antibody Combination Authorized For Emergency Use In US For Pre-exposure Prophylaxis Of COVID-19   RTTNews
07:37PM EST  EVUSHELD (formerly AZD7442) long-acting antibody combination authorized for emergency use in the US for pre-exposure prophylaxis (prevention) of COVID-19   Business Wire
11:13AM EST  AstraZeneca's EVUSheld Authorized For COVID Prevention   Benzinga
Dec 7, 2021
01:03PM EST  Mix & Match Pfizer, AstraZeneca COVID-19 Vaccine With Moderna Shows Improved Immune Response   Benzinga
10:18AM EST  Daiichi Sankyo Reports Co. Development Program With AstraZeneca, Datopotamab Deruxtecan Continues To Show Durable Response, Disease Control In Patients with Metastatic Triple Negative Breast Cancer   Benzinga
10:03AM EST  Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021   Benzinga
08:26AM EST  The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Dar   Benzinga
07:44AM EST  Ionis, AstraZeneca Ink Licensing Pact For Eplontersen In Protein Misfolding Disorder   Benzinga
06:11AM EST  A Peek Into The Markets: US Stock Futures Higher Following Monday's Rally   Benzinga
05:05AM EST  Jefferies Downgrades AstraZeneca to Hold   Benzinga
04:41AM EST  Ionis Announced Collaboration With AstraZeneca to Develop and Commercialize Eplontersen; Ionis to Receive $200M Upfront, Up to $485M in Development and Approval Milestones, Up to $2.9B in Sales-related Milestone Payments   Benzinga
Dec 6, 2021
01:50PM EST  CNN Reporter Tweets 'Good news on Omicron and vaccines: "The early indication is that you are going to be protected against serious illness with two doses of mRNA-containing vaccines. And the booster dose can increase antibodies,"'   Benzinga
10:27AM EST  UPDATE: Children Aged 5-11 Required To have At Least 1 COVID Vaccine Shot For Indoor Activities Starting Dec. 14   Benzinga
08:09AM EST  Johnson & Johnson Booster COVID-19 Shot Shows Encouraging Action After Pfizer/BioNTech Jab   Benzinga
Dec 5, 2021
09:15AM EST  CDC Director Walensky Said Omicron Covid-19 Cases Found in at Least 15 U.S. States; Said Delta Variant of Covid-19 Still Makes Up Majority of U.S. Cases   Benzinga
Dec 3, 2021
10:30AM EST  AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care   Business Wire
07:10AM EST  AstraZeneca :data To Reinforce Practice-changing Potential Of ENHERTU With Analyses From DESTINY-Breast03 Trial   RTTNews
07:00AM EST  AstraZeneca Reinforces Leadership in Breast Cancer at SABCS 2021 With New Data Underscoring Ambition to Redefine Cancer Care   Business Wire
06:50AM EST  AstraZeneca Blocks SOBI's $8B Buyout, Advent Withdraws The Bid - Report   Benzinga
05:07AM EST  AstraZeneca Blocked $7.6B Takeover of Swedish Orphan Biovitrum AB by Withholding its 8% Stake in Drugmaker from a Buyout offer by Advent International and Singapore Wealth fund GIC   Benzinga
04:53AM EST  AstraZeneca Announced Data From Destiny-Breast03 Will Reaffirm Efficacy Of Enhertu   Benzinga
04:52AM EST  India's Health Ministry Said India's Serum Institute Raises AstraZeneca COVID-19 Vaccine Monthly Production Capacity to 250M-275M Doses   Benzinga
Dec 2, 2021
01:53PM EST  President Biden Says Team Is Working With Vaccine Firms For Contingency Plan For Vaccines, Boosters   Benzinga
12:48PM EST  Possible New Links Identified With AstraZeneca COVID-19 Shot, Blood Clots   Benzinga
04:56AM EST  Possible New Links Between AstraZeneca Vaccine and Blood Clots Found   Benzinga
Dec 1, 2021
12:03PM EST  Former German PM Merkel Proposes Mandatory COVID Shots Starting Feb. 2022   Benzinga
09:42AM EST  European Medicines Agency Has Approved A New Site To Manufacture AstraZeneca's Vaxzevria COVID-19 Vaccine Finished Product   Benzinga
07:18AM EST  WHO Official Says Some of the Early Indications Is That Most Omicron Cases Are Mild, No Severe Cases   Benzinga
05:45AM EST  Norway Detected First Two Cases of Omicron Covid Variant   Benzinga
05:11AM EST  Japan Confirmed Second Case of Omicron Variant of the Covid-19 on Wednesday   Benzinga
05:00AM EST  Israel's Health Minister Nitzan Horowitz Said Individuals Fully Vaccinated Against Corona Within Six Months or With the Booster are Protected Against the Omicron Variant   Benzinga
Nov 30, 2021
04:47PM EST  The Daily Biotech Pulse: Cumberland Jumps On FDA Nod, Regeneron Says Antibody Treatment May Be Less Effective Against Omicron, ImmunoGen Readout   Benzinga
04:44PM EST  AstraZeneca-Merck's Lynparza Under FDA Priority Review For Breast Cancer Setting   Benzinga
04:42PM EST  AstraZeneca And Merck Announce FDA Has Accepted Submission Of Supplemental New Drug Application For LYNPARZA   Benzinga
04:42PM EST  Two Israeli Doctors Infected with Omicron Variant   Benzinga
04:40PM EST  China Xinhua News Says No Omicron Cases Reported on Chinese Mainland So Far   Benzinga
04:39PM EST  U.S. Equity Futures, European Markets Fall Following Moderna CEO Comments on Vaccines Likely Less Effectiveness Against Omicron Variant   Benzinga
04:39PM EST  Dutch Authorities Said Omicron Variant Was Detected in the Netherlands on Nov. 19, Before S. Africa Flights   Benzinga
04:39PM EST  Genetron Health Announced Late Monday, A Co-Development Agreement with AstraZeneca R&D China for Personalized MRD Tests for Solid Tumors in China   Benzinga
04:39PM EST  Moderna CEO Said in Financial Times Interview Vaccines are Likely Less Effective against Omicron; Said Mutations Mean Existing Vaccines Likely Need Modifying   Benzinga
06:30AM EST  LYNPARZA(r) (olaparib) Granted Priority Review in the US for BRCA-Mutated HER2-Negative High-Risk Early Breast Cancer   Business Wire
02:05AM EST  AstraZeneca's Lynparza SNDA Granted Priority Review In US For BRCA-mutated HER2-negative High-risk Early Breast Cancer   RTTNews
Nov 29, 2021
10:00PM EST  Genetron Health Announces Co-Development Agreement with   GlobeNewswire Inc
06:26AM EST  World Health Organization Tweeted Earlier "We don't yet know whether Omicron is associated with more: -transmission -severe #COVID19 disease -risk of reinfections -risk of evading vaccines. Scientists at WHO & around the   Benzinga
05:58AM EST  Italy's Radiocor Says Italy Reported Four Omicron Variant Cases   Benzinga
Nov 28, 2021
05:07PM EST  NIH Director Collins Said Current Vaccinations Likely to Protect Against Omicron   Benzinga
09:14AM EST  National Institute of Allergy and Infectious Diseases Director Fauci Tells ABC News Too Early to Say if We Need New Lockdowns or Mandates   Benzinga
Nov 27, 2021
09:23AM EST  Two cases of Omicron Variant Detected in UK: Individuals in Chelmsford and Nottingham had Traveled to Southern Africa   Benzinga
Nov 26, 2021
05:43AM EST  France, Czech Republic, Singapore Among Countries Reported to Restrict Travel from Southern Africa Due to "Nu" Variant   Benzinga
05:15AM EST  Total of 84 Confirmed Cases of COVID-19 Variant B.1.1.529 With 77 in S. Africa, 4 in Botswana, 2 in Hong Kong, 1 in Israel   Benzinga
05:12AM EST  U.S. Equity Futures Sharply Lower; Covid-Related Stocks Surge on Reports of New, Heavily-Mutated Strain, Feared to be More Infectious than Delta Variant   Benzinga
05:09AM EST  Israeli, Who Returned from Malawi, Tested Positive for New Highly-Mutated Covid-19 Strain Reported in S. Africa   Benzinga
Nov 24, 2021
06:44AM EST  World Health Organization Issues Interim Statement on Covid-19 Vaccination for Children and Adolescents, Says They Have Lower Risk of Severe Disease   Benzinga
Nov 23, 2021
07:00PM EST  Follows important findings from the TATTON1 study of the combination in EGFR inhibitor refractory lung cancer patients whose tumors harbor aberrations of MET   GlobeNewswire Inc
05:03PM EST  'AstraZeneca vaccine may give longer protection that is shielding UK from new Covid wave' -The Telegraph Report   Benzinga
02:16PM EST  Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst   Benzinga
Nov 22, 2021
12:41PM EST  EU Says Decision On J&J COVID-19 Booster Shot Expected 'Within Weeks'   Benzinga
Nov 19, 2021
09:55AM EST  Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations   PR Newswire
Nov 18, 2021
10:00AM EST  EU Drug Regulator EMA Says Most Likely Beginning Of Next Year Will Proceed 'Rapidly' Towards Conclusion Of Approval For AstraZeneca COVID Antibody Drug   Benzinga
09:06AM EST  AstraZeneca CEO Soriot Says Main Use Of Antibody Cocktail Would Be To Prevent COVID-19 And Offer More Protection For People Who Don't Respond To Vaccines   Benzinga
08:06AM EST  AstraZeneca And Daiichi Sankyo Company Announce The First Patient Was Dosed In The Global TROPION-Breast01 Phase 3 Trial Evaluating The Efficacy And Safety Of Datopotamab Deruxtecan   Benzinga
07:55AM EST  The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings   Benzinga
07:24AM EST  AstraZeneca's COVID-19 Antibody Shows 83% Protection Over Six Months   Benzinga
07:00AM EST  New Analyses of Two AZD7442 COVID-19 Phase III Trials in High-Risk Populations Confirm Robust Efficacy and Long-Term Prevention   Business Wire
05:03AM EST  AstraZeneca Says Trial Data Shows Its Treatment Cuts Risk of Symptomatic COVID-19 By 83%   Benzinga
Nov 17, 2021
10:10AM EST  AZN:LOKELMA Granted Fast Track Designation In US To Reduce Cardiovascular Outcomes On Chronic Hemodialysis With HK   RTTNews
10:04AM EST  AstraZeneca's LOKELMA Granted Fast Track Designation In U.S. To Reduce Cardiovascular Outcomes In Patients On Chronic Hemodialysis With Hyperkalemia   Benzinga
10:03AM EST  LOKELMA(r) Granted Fast Track Designation in the US to Reduce Cardiovascular Outcomes in Patients on Chronic Hemodialysis With Hyperkalemia   Business Wire
Nov 15, 2021
02:38PM EST  AstraZeneca, Moderna Shares Early Cut Data For mRNA Candidate In Heart Failure   Benzinga
10:52AM EST  Moderna Posts Interim Data From mRNA Triplet Program In Solid Tumors   Benzinga
Nov 12, 2021
03:12PM EST  Mid-Afternoon Market Update: Dow Surges 150 Points; Team Shares Drop   Benzinga
12:17PM EST  Mid-Day Market Update: Everspin Jumps After Q3 Results; Acutus Medical Shares Plummet   Benzinga
10:14AM EST  Mid-Morning Market Update: Markets Rise; AstraZeneca's COVID-19 Vaccine Turns Profitable In Third Quarter   Benzinga
08:10AM EST  Recap: AstraZeneca Q3 Earnings   Benzinga
07:47AM EST  The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares   Benzinga
06:02AM EST  AstraZeneca's COVID-19 Vaccine Turns Profitable In Q3; Reaffirms FY21 Guidance   Benzinga
05:51AM EST  A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report   Benzinga
05:09AM EST  AstraZeneca PLC Q3 Adj EPS $1.08 Beat $0.62 Est; Revenue $9.87B Inline With Est   Benzinga
04:26AM EST  Earnings Scheduled For November 12, 2021   Benzinga
Nov 11, 2021
08:36AM EST  International companies to host live webcasts at Deutsche Bank's Depositary   PR Newswire
Nov 10, 2021
06:56AM EST  AstraZeneca Plans To Set Up Separate Division For Vaccines & Antibody Therapies - Report   Benzinga
Nov 9, 2021
12:01PM EST  AstraZeneca Is Creating A Dedicated Vaccines And Immune Therapies Unit, Team Will Be Led By Iskra Reic, A Senior Executive   Benzinga
11:25AM EST  AstraZeneca's COVID-19 Antibody Cocktail Clears First Step for Registration in Australia   Benzinga
Nov 8, 2021
08:29AM EST  The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More   Benzinga
05:04AM EST  AstraZeneca Says New Sub-Analyses Further Support Consistency Of Farxiga'S Cardiorenal And Mortality Benefits In Treating Chronic Kidney Disease   Benzinga
05:01AM EST  AstraZeneca Says Fasenra Granted Orphan Drug and Fast Track Designations by the FDA For Eosinophilic Gastritis And Eosinophilic Gastroenteritis   Benzinga
Nov 5, 2021
09:36AM EDT  AstraZeneca Announced Calquence Shows Durable Efficacy and Favourable Tolerability vs Standards of Care Across Multiple Analyses in Chronic Lymphocytic Leukaemia   Benzinga
07:00AM EDT  AstraZeneca Advances Ambition to Redefine Care for Blood Cancer at ASH 2021   Business Wire
Nov 3, 2021
10:11AM EDT  PhaseBio's Bentracimab Reverses Ticagrelor-Associated Antiplatelet Activity In Mid-Stage Study   Benzinga
09:17AM EDT  Integral Molecular Enters Into Antibody License Agreement With AstraZeneca For Oncology Therapeutics   Benzinga
08:06AM EDT  Integral Molecular Reaches Antibody License Agreement With AstraZeneca For Oncology Therapeutics   RTTNews
08:03AM EDT  Integral Molecular Enters into Antibody License Agreement with AstraZeneca for   PR Newswire
Nov 2, 2021
10:52AM EDT  SAGA Diagnostics Reports Assay Development Deal With AstraZeneca, No Terms Disclosed   Benzinga
Nov 1, 2021
11:08AM EDT  SAPHNELO Consistently Reduces Systemic Lupus Erythematosus Disease Activity Regardless of Disease Duration and Prior Treatment   Business Wire
07:41AM EDT  AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio   Benzinga
07:00AM EDT  AstraZeneca Awards 30 Nonprofit Organizations through the ACT on Health Equity Community Solutions Challenge to Actively Address Health Disparities   Business Wire
06:16AM EDT  AstraZeneca To Offload Some Drug Rights To Covis Pharma For $270M   Benzinga
04:54AM EDT  HUTCHMED, AstraZeneca Initiate SAMETA Global Phase III Trial of Savolitinib in Combination with PD-L1 Inhibitor IMFINZI in Patients with MET-Driven Advanced Papillary Renal Cell Carcinoma   Benzinga
04:50AM EDT  AstraZeneca to Transfer Global Rights for Eklira and Duaklir to Covis Pharma for $270M   Benzinga
Oct 28, 2021
02:50PM EDT  White House Says Decisions On Vaccine Intellectual Property Waivers Will Not occur At G20 But At Coming Trade Meeting   Benzinga
12:20PM EDT  Millions Of JNJ COVID-19 Shots Sit Idle At Emergent's Baltimore Plant: Reuters   Benzinga
Oct 26, 2021
08:36AM EDT  The Daily Biotech Pulse: Moderna Gains On Vaccine News, Novartis Reports Q3 Beat, Adcom Reviews Authorization Of Pfizer-BioNTech's Vaccine For Children   Benzinga
08:07AM EDT  AstraZeneca's Imfinzi/Chemo Combo Strikes First Immunotherapy Wins In Bile Duct Cancer Trial   Benzinga
Oct 25, 2021
04:25PM EDT  AstraZeneca Announces High-Level Results From TOPAZ-1 Phase III Trial Of IMFINZI In Combination With Standard-Of-Care Chemotherapy; Says Independent Data Monitoring Committee Concluded Trial Met Primary Endpoint   Benzinga
04:21PM EDT  IMFINZI Plus Chemotherapy Significantly Improved Overall Survival in 1st-Line Advanced Biliary Tract Cancer in TOPAZ-1 Phase III Trial at Interim Analysis   Business Wire
08:23AM EDT  AstraZeneca Says Second Clinical Trial Collaboration Initiated To Evaluate Datopotamab Deruxtecan In Combination With KETRUDA In Patients With Metastatic Non-Small Cell Lung Cancer   Benzinga
02:07AM EDT  AstraZeneca Reports Positive High-level Results From TOPAZ-1 Phase 3 Trial In 1st-line Advanced Biliary Tract Cancer   RTTNews
Oct 21, 2021
12:10PM EDT  AstraZeneca Pulls Plug On MCL-1 Cancer Drug Trial   Benzinga
Oct 20, 2021
09:00AM EDT  AstraZeneca Announces Winners and Recognizes Oncology Change Makers in Third Annual Cancer Community Awards   Business Wire
05:03AM EDT  Oxford Vaccine Head Said Delta Subvariant Unlikely to Change Covid Situation Dramatically   Benzinga
Oct 19, 2021
05:46AM EDT  AstraZeneca, Unilever Tumble As FTSE 100 Struggles With Rising Energy Prices   Benzinga
Oct 18, 2021
10:14AM EDT  Earnings Season Continues with State Street, Albertsons, and Sandvik Announcing on Monday Morning   Benzinga
Oct 15, 2021
03:04PM EDT  AstraZeneca Wins Ruling Upholding Farziga Patent   Benzinga
07:44AM EDT  The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO   Benzinga
07:00AM EDT  IMFINZI Plus Tremelimumab Significantly Improved Overall Survival in HIMALAYA Phase III Trial in 1st-Line Unresectable Liver Cancer   Business Wire
05:09AM EDT  AstraZeneca Announced Himalaya Phase III Trial Met Primary Endpoint of Survival in 1st-line Unresectable Liver Cancer   Benzinga
Oct 13, 2021
05:11AM EDT  AstraZeneca Covid-19 Vaccine Will No Longer Be Made in Australia Due to Demand for Pfizer, Moderna Vaccines   Benzinga
Oct 12, 2021
08:13AM EDT  The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology   Benzinga
Oct 11, 2021
01:33PM EDT  AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial   Benzinga
09:05AM EDT  AstraZeneca's Global Product Lead Says Co. In Talks With Regulators About Pediatric Study For COVID-19 Treatment, Hope To Begin Early In 2022   Benzinga
06:36AM EDT  'Russian spies 'stole formula for Oxford/Astra Zeneca Covid jab and used it to create Sputnik vaccine'' - The Sun   Benzinga
05:09AM EDT  AstraZeneca Announced AZD7442 Reduced Risk of Developing Severe Covid-19 or Death in TACKLE Phase III Outpatient Treatment Trial; Trial Met Primary Endpoint   Benzinga
01:35AM EDT  Why New COVID-19 Vaccination-Related Rules In This Australian State Have Small Businesses Worried   Benzinga
Oct 8, 2021
07:05AM EDT  AstraZeneca: FDA Grants Orphan Drug Designation For Tezepelumab In The US For Eosinophilic Esophagitis   RTTNews
07:00AM EDT  AstraZeneca Reports Tezepelumab Granted Orphan Drug Designation In US For Eosinophilic Esophagitis   Benzinga
07:00AM EDT  Tezepelumab granted Orphan Drug Designation in the US for eosinophilic esophagitis   Business Wire
Oct 7, 2021
09:59AM EDT  AstraZeneca's Debt Overview   Benzinga
09:46AM EDT  WHO's Tedros Says There Is Enough Vaccine Supply To Reach 40% Of World By End Of 2021, 70% By Mid 2022 If 'Distributed Equitably'   Benzinga
09:37AM EDT  AstraZeneca Granted Orphan Designation For Tezepelumab   Benzinga
Oct 6, 2021
12:12PM EDT  White House Advisor Dr. Fauci Says Merck's COVID-19 Pill Does Not Remove The Need For A Vaccine   Benzinga
11:04AM EDT  Best Crypto PR Agencies You Must Know   Benzinga
Oct 5, 2021
08:31AM EDT  AstraZeneca Seeks Emergency Use Nod For COVID-19 Drug To Prevent Infection   Benzinga
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
07:00AM EDT  AZD7442 Request for Emergency Use Authorization for COVID-19 Prophylaxis Filed in US   Business Wire
04:56AM EDT  Astrazeneca Submitted Request to FDA Emergency Use Authorization for AZD7442 for Prophylaxis of Symptomatic Covid-19   Benzinga
Oct 4, 2021
07:06AM EDT  Compugen To Receive $6 Mln Milestone Payment From AstraZeneca   RTTNews
07:03AM EDT  Compugen Receives $6M Milestone Payment From AstraZeneca Triggered By First Patient Dosed With TIGIT Bispecific Derived From COM902   Benzinga
07:01AM EDT  Compugen Announces Milestone Payment from AstraZeneca Triggered by First   PR Newswire
07:00AM EDT  ENHERTU(r) (fam-trastuzumab deruxtecan-nxki) Granted Breakthrough Therapy Designation in US for Patients with HER2-Positive Metastatic Breast Cancer Treated with One or More Prior Anti-HER2-Based Regimens   Business Wire
05:13AM EDT  AstraZeneca Announced Enhertu Granted FDA Breakthrough Therapy Designation for Breast Cancer   Benzinga
Oct 1, 2021
09:06AM EDT  EMA's Risk Assessment Committee Finds Link Of Rare Cases Between JNJ COVID-19 Shot, Blood Clots   Benzinga
07:56AM EDT  The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO   Benzinga
Sep 30, 2021
03:16PM EDT  AstraZeneca COVID-19 Jab Shows 74% Efficacy In US Trial   Benzinga
07:43AM EDT  The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug   Benzinga
Sep 29, 2021
04:36PM EDT  NIH-Backed US Study Of Mixed COVID-19 Vaccines Regime To Conclude Soon: CNBC   Benzinga
02:28PM EDT  Why AstraZeneca And Pfizer Shares Are Moving Today   Benzinga
08:13AM EDT  The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug   Benzinga
07:07AM EDT  Fortress Biotech Announces Receipt Of Notice Of Option Exercise From AstraZeneca To Fully Acquire Caelum Biosciences, A Company Founded By Fortress Biotech; Option Triggers Upfront Payment Of $150M To Caelum, Of Which $64M Is Payable To Fortress   Benzinga
07:00AM EDT  AstraZeneca Healthcare Foundation Awards Seven US Nonprofits More Than $900k to Improve Heart Health and Advance Health Equity   Business Wire
05:06AM EDT  AstraZeneca's Alexion has Exercised its Option to Acquire all Remaining Equity in Caelum Biosciences for $150M Plus Up tp $350M in Milestone Payments   Benzinga
Sep 28, 2021
11:03AM EDT  'AstraZeneca to develop vaccine for treating cancer and heart conditions' -Earlier Business Insider India Article   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC